DIRS.INFO The most relevant business & tech news

☆ Thursday's analyst calls: Discount retailers upgraded, more good news for Carvana, tough outlook for CVS
▼ + stars: | 2024-05-02 | by ( Hakyung Kim | ) www.cnbc.com time to read: +8 min

Thursday's analyst calls feature upgrades to discount retailers TJX and Burlington and used car outlet Carvana, while there was more bad news for CVS Health following a tough earnings report Wednesday. He also raised his price target to $130 from $70, or 49.2% above Wednesday's close price. He lowered his price target by $25 to $60, or just 5.6% higher from Wednesday's close price. Analyst Jay Sole also lifted his price target to $132 from $104, indicating nearly 41% upside from Wednesday's close. He raised his price target to $212 from $126, suggesting shares could gain 19.1% from where they closed Wednesday.

Persons: Morgan Stanley, Joseph Moore, Moore, Samik Chatterjee, Chatterjee, Tal Liani, Liani, — Hakyung Kim, JPMorgan Carvana, Rajat Gupta, Gupta, Kevin Caliendo, Caliendo, Jay Sole, Sole, BURL, — Hakyung Kim —, Michael Bloom Organizations: CNBC, CVS Health, UBS, CVS, JPMorgan, Qualcomm, Wall Street, Samsung, Huawei, Edge, headwinds, " Bank of America, Microsoft, Burlington Discount, TJX Companies, Burlington Stores, Burlington Locations: Burlington, Carvana, CY24, seasonality, optionality, Maxx

☆ CVS posts big earnings miss, cuts profit outlook on higher medical costs
▼ + stars: | 2024-05-01 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

CVS Health on Wednesday reported first-quarter revenue and adjusted earnings that missed expectations and slashed its full-year profit outlook, citing higher medical costs that are dogging the U.S. insurance industry. The drugstore chain expects 2024 adjusted earnings of at least $7 per share, down from a previous guidance of at least $8.30 per share. The company said its new outlook assumes that higher medical costs in its insurance business during the first quarter will persist throughout the year. Medicare Advantage, a privately run health insurance plan contracted by Medicare, has long been a key source of growth and profits for the insurance industry. Excluding certain items, such as amortization of intangible assets and capital losses, adjusted earnings per share were $1.31 for the quarter.

Persons: LSEG, Karen Lynch, Caremark, Tyson Foods, CVS's Caremark, Cuban's Organizations: CVS Health, CVS, Aetna, UnitedHealth, Medicare, LSEG, Blue, Amazon Pharmacy, Oak Street Health Locations: California

☆ A CVS Health pharmacy in Vegas becomes first to join new national pharmacy union
▼ + stars: | 2024-04-26 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

A CVS Omicare pharmacy in Las Vegas has become the first location to join a new national pharmacy union, a milestone as organizers try to help thousands of U.S. pharmacy workers address what they call unsafe working conditions. Nearly 30 pharmacy staff at the Las Vegas branch of CVS's Omnicare won their union election on Thursday by a landslide margin of 87% to 13%. Those workers now join The Pharmacy Guild, which will represent them in labor negotiations with CVS. The Pharmacy Guild will now work to strike a union contract with CVS to address the concerns of Omnicare workers in Las Vegas. The Pharmacy Guild is seeing momentum build in other parts of the country.

Persons: CVS's Omnicare, Shane Jerominski, Jerominski Organizations: CVS, Las, Pharmacy, CNBC, IAM Healthcare, Walgreens, Rite - Locations: Las Vegas, CVS's, Nevada, Rhode Island

☆ Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly
▼ + stars: | 2024-04-26 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

It's a week jam-packed with notable events, including earnings from Apple , Amazon and Eli Lilly . He also said to pay attention to Wednesday's Federal Reserve meeting and Friday's employment figures from the Department of Labor. "We have to run such a ridiculous gauntlet next week that I have no idea how it'll play out," he said. Wednesday also brings reports from Wingstop , Carvana and Marriott . Apple will report on Thursday, and Cramer noted there's been a lot of negative sentiment from investors surrounding the company.

Persons: CNBC's Jim Cramer, Eli Lilly, Jensen Huang, Cramer, it's, he'll, Seagen, there's Organizations: Apple, Federal Reserve, Department of Labor, Nvidia, Food and Drug Administration, Starbucks, CVS, Pfizer, Amazon, Walgreens, Marriott, Vision Locations: It's, China, Wingstop, Carvana

☆ Cramer's Lighting Round: Allstate is a buy
▼ + stars: | 2024-02-09 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Hawkins' year-to-date stock performance. Stock Chart Icon Stock chart icon PayPal's year-to-date stock performance. Stock Chart Icon Stock chart icon Kimberly-Clark's year-to-date stock performance. Stock Chart Icon Stock chart icon CVS's year-to-date stock performance. Stock Chart Icon Stock chart icon Lennar's year-to-date stock performance.

Persons: Hawkins, Kimberly, Clark, it's, It's, Lennar Organizations: PayPal

☆ Walgreens is following Mark Cuban's blueprint as it embarks on a big strategy shift for prescription drugs
▼ + stars: | 2024-01-05 | by ( ) www.businessinsider.com time to read: +5 min

Pharmacies are changing how they get paid, and Walgreens wants a piece of the action. It's a departure from the traditional, complicated way drugs are paid for, and proponents say it could make drug pricing more transparent and predictable. It's not a given patients will pay less for drugs at the pharmacy counter under this kind of model. These companies are taking cues from Mark Cuban's Cost Plus Drugs, which is starting to gain traction in the market. The big question is whether Walgreens can compete with CVS and other pharmacies in delivering those extra pharmacy and healthcare services.

Persons: Tim Wentworth, Mark, Wentworth, Borja, Hojas, they're, Caremark, Brian Tanquilut, Tanquilut, CVS, Cigna, Mark Cuban's, It's, Rosalind Brewer Organizations: Walgreens, Business, CVS Health, Getty, CVS, Jefferies, Health Locations: California

☆ CVS's model will stabilize retail pharmacy margins, says Scott Gottlieb
▼ + stars: | 2023-12-05 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCVS's model will stabilize retail pharmacy margins, says Scott GottliebDr. Scott Gottlieb, former FDA commissioner, joins 'The Exchange' to discuss CVS Health's drug pricing, the role of AI in medicine, and more.

Persons: Scott Gottlieb Dr, Scott Gottlieb Organizations: FDA, CVS

☆ How Mark Cuban forced the biggest US pharmacy to upend its business
▼ + stars: | 2023-12-05 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +5 min

The new program includes a set markup for medication costs, a step toward drug pricing transparency. The retailer has been facing pressure from new models like Mark Cuban Cost Plus Drugs. They've been especially focused on pharmacy-benefit managers and the lack of transparency around how much drugs cost. How Mark Cuban changed drug pricingCuban's pharmacy buys drugs directly from manufacturers and sells them to consumers at a 15% markup, plus pharmacy fees. AdvertisementBut the announcement looks to be a step in the right direction for drug pricing transparency.

Persons: —, Mark, Prem Shah, Mark Cuban, GoodRx, PBMs, Kroger, it's Organizations: CVS, Cuban, Plus, Service, Mark Cuban, Federal, US Federal Trade Commission, CVS Health, Kroger, Walgreens, Drug, Wall Street Locations: California

☆ CVS to change how it prices prescription drugs with new pharmacy reimbursement model
▼ + stars: | 2023-12-05 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

CVS Health on Tuesday said it will revamp how it prices prescription drugs and scrap a complex model that typically sets how much pharmacies get reimbursed and what patients pay for those medications. CVS' new model could change the cost of prescription drugs for some patients, but it will not necessarily make all medicine cost less, company executives said. Lynch told CNBC: "It's a cost plus markup, plus a fee. Billionaire Mark Cuban last year launched an online pharmacy that takes a similar approach to CVS' new reimbursement model. The company, called Cost Plus Drugs, aims to drive down the price of medicines broadly by selling them at a set 15% markup over their cost, plus pharmacy fees.

Persons: Karen Lynch, Lynch, Prem Shah, markups, Billionaire Mark Cuban, Cuban Organizations: CVS Health, CVS, CNBC, Billionaire

☆ Cramer's Lighting Round: 'Stay away' from HF Sinclair
▼ + stars: | 2023-10-26 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Toast's year-to-date stock performance. Stock Chart Icon Stock chart icon CVS's year-to-date stock performance. Stock Chart Icon Stock chart icon HF Sinclair's year-to-date stock performance. Stock Chart Icon Stock chart icon Exact Sciences' year-to-date stock performance. Stock Chart Icon Stock chart icon SoFi's year-to-date stock performance.

Persons: I'd, It's, you've, I've, it's Organizations: CVS, Gillette, Resources, Sinclair

☆ CVS to pull certain cold medicines containing decongestant phenylephrine from store shelves
▼ + stars: | 2023-10-19 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

CVS is removing some of the most common cough and cold medicines from its store shelves and will no longer sell them, a company spokesperson told CNBC on Thursday. However, CVS is voluntarily removing certain cough and cold medicines that contain phenylephrine as the only active ingredient from stores. They added that CVS stores will continue to offer other oral cough and cold products to meet patient needs. Oral products that list phenylephrine as its only active ingredient include Sudafed PE, which is marketed by Johnson & Johnson's consumer health spinoff Kenvue . Pulling oral phenylephrine from the market entirely could affect CVS and other retail pharmacy chains, which rake in revenue from selling over-the-counter cold and allergy pills.

Persons: Johnson, Kenvue Organizations: CNBC, Food and Drug Administration, FDA, CVS, Street Journal Locations: U.S

☆ Cramer's Lightning Round: 'I'm moving on' from Herbalife
▼ + stars: | 2023-10-10 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Spirit AeroSystems' year-to-date stock performance. Stock Chart Icon Stock chart icon CVS's year-to-date stock performance. Stock Chart Icon Stock chart icon Abbott's year-to-date stock performance. Stock Chart Icon Stock chart icon Viking's year-to-date stock performance. Stock Chart Icon Stock chart icon Herbalife's year-to-date stock performance.

Persons: AeroSystems, Abbott, Elon Musk, I'm, I've, Jim Cramer's Organizations: Honeywell, CVS, Elon

☆ Cramer's Lightning Round: Powell Industries is 'a winner'
▼ + stars: | 2023-09-27 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Solaris' year-to-date stock performance. Stock Chart Icon Stock chart icon CVS's year-to-date stock performance. Stock Chart Icon Stock chart icon Powell Industries' year-to-date stock performance. Stock Chart Icon Stock chart icon Cal-Maine Foods' year-to-date stock performance. Stock Chart Icon Stock chart icon Boeing's year-to-date stock performance,Boeing : "They sold a lot of those contractors, that was their thing...In retrospect, I think it was a big mistake.

Persons: they've, you've Organizations: Solaris, Powell Industries, Cal, Maine Foods, Maine, Boeing

☆ Cramer's Lightning Round: Enbridge is a buy
▼ + stars: | 2023-09-12 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Magellan's year-to-date stock performance. Stock Chart Icon Stock chart icon Edwards Lifesciences' year-to-date stock performance. Stock Chart Icon Stock chart icon International Flavors & Fragrances' year-to-date stock performance. I have no idea what's happening, why it's just completely falling apart..."Stock Chart Icon Stock chart icon CVS's year-to-date stock performance. Stock Chart Icon Stock chart icon Honeywell's year-to-date stock performance.

Persons: It's, Edwards Lifesciences, Edwards, it's, Karen Lynch, IT's, that's what's, Morgan Stanley, I'm Organizations: Honeywell, Laguna, Charitable

☆ Stock Market Today: Dow, Nasdaq Open Higher; Cisco, Walmart Stocks in Focus
▼ + stars: | 2023-08-17 | by ( ) www.wsj.com time to read: +1 min

Ten-year Treasury yields are up again after settling at their highest level since 2008, an ascent that is raising concern on Wall Street about the potential fallout for stocks. Yields have been driven up mostly by the strength of the U.S. economy, and the prospect of inflation remaining stubbornly high. Stocks were in the red following two days of losses spurred in part by higher yields. The S&P 500 and Dow industrials were modestly lower, while the Nasdaq Composite was off about 0.5%. Ten-year Treasury yields rose above 4.3%, after settling at 4.258% Wednesday.

Persons: Stocks, Dow industrials Organizations: Labor Department, Retail, Walmart, Nasdaq, Hawaiian Electric, Moderna, Global, Japan’s Nikkei Locations: U.S, Maui, Europe, Shanghai

☆ Cramer's Lightning Round: Don't touch ChargePoint
▼ + stars: | 2023-08-15 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Opendoor's year-to-date stock performance. Stock Chart Icon Stock chart icon Nextera Energy's year-to-date stock performance. Stock Chart Icon Stock chart icon CVS's year-to-date stock performance. Because of shrinkage, because of pilferage, because of those darned plastic things that are like in front of every single thing you want to buy..."Stock Chart Icon Stock chart icon ChargePoint's year-to-date stock performance. Stock Chart Icon Stock chart icon Volaris' year-to-date stock performance.

Persons: Nextera, it's, I'm, ChargePoint's, Volaris, I've Organizations: Nextera Locations: Mexico

☆ The telehealth services we all relied on during COVID are fading away — but telemedicine may be entering a new era as providers look to bring the clinic home
▼ + stars: | 2023-06-28 | by ( Natalie Rahhal | ) www.businessinsider.com time to read: +7 min

But it's exhausted the capabilities of asynchronous care, one healthcare expert told Insider. The answer may lie in in-home monitoring technology, healthcare experts told Insider, which could be the next phase of telemedicine. Another example of a telemedicine model that uses in-home monitoring to expand access to care is the startup Bicycle Health. But there are obstacles to getting this kind of care to patients, including doctors' resistance to telemedicine and federal and state regulation. "For one-quarter century, this has been the domain of states," Kyle Zebley, senior vice president of public policy at the American Telemedicine Association, told Insider.

Persons: it's, Alana Saltz, Saltz, Ateev, Mehrotra, Danny Nieves, Kim, Nieves, telehealth, —, Kyle Zebley, Zebley, that's Organizations: Healthcare, Morning, Harvard University, Technology, Health, Bicycle Health, American Telemedicine Association, McKinsey Locations: COVID, —

☆ Meet the typical CVS shopper: a white, Gen X, college-educated city dweller earning a high income
▼ + stars: | 2023-04-04 | by ( Dominick Reuter | ) www.businessinsider.com time to read: +3 min

CVS's average customer is a white, urban Gen Xer earning a high annual income. Numerator found that CVS's typical shopper is a white, urban Gen Xer who has a college education and an annual income of more than $80,000. In addition to OTC pain medication and cough remedies, the typical retail shopper often prefers to buy candies, chocolates, and bottled water. Just 1.6% of a CVS shopper's total dollars are spent at CVS, compared with 6.8% of their spending on Amazon. At other retailers, the CVS shopper buys more fresh garlic, hand sanitizer, bar soap, and non-dairy milk alternatives than the national average shopper.

☆ A disappointing 2022 has led some Goldman Sachs partners to ask: Is it time for a change at the top?
▼ + stars: | 2023-02-09 | by ( Dan Defrancesco | ) www.businessinsider.com time to read: +6 min

On tap, we've got stories on why not-so-flashy land is actually the hottest investment on Wall Street, the firms minting money by navigating FTX's bankruptcy, and the coolest houses on Airbnb. It's only February, but the Ides of March might be coming to Goldman Sachs. We've talked at length over how people are looking to pin the blame on Solomon as things have soured at Goldman. Certain issues have been easier to overlook than others, but the bank recently broke a cardinal rule of Wall Street: Don't mess with bankers' compensation. Forget beachfront, the hottest real estate for Wall Street is industrial land.

☆ CVS scales up its vertical ecosystem in $10.6B Oak Street Health deal
▼ + stars: | 2023-02-08 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCVS scales up its vertical ecosystem in $10.6B Oak Street Health dealCVS Health CEO Karen Lynch joins 'Closing Bell' to discuss CVS's latest primary care deal with Oak Street Health, mapping out the end of Covid, and providing women with health care products, including abortion pills.

☆ CVS just struck a $10.6 billion deal with Oak Street Health to become a one-stop shop for healthcare
▼ + stars: | 2023-02-08 | by ( Alex Bitter | ) www.businessinsider.com time to read: +3 min

CVS Health is buying Oak Street Health for $10.6 billion, its biggest move into primary care yet. But the Oak Street deal will add full-service medical clinics to what CVS offers. Competition is heating up among major healthcare companies to be the first place you go when you need medical care. Oak Street Health CEO Mike Pykosz Oak Street HealthCVS will pay a premium for Oak Street compared to the clinic operator's IPO price. In Wednesday's all-cash deal, CVS valued Oak Street at $39 a share.

☆ Earnings playbook: Your best moves ahead of Chipotle, Disney and the second half of reporting season
▼ + stars: | 2023-02-05 | by ( Fred Imbert | ) www.cnbc.com time to read: +7 min

Roughly 50% of S & P 500 companies have posted earnings thus far, and the results have been mixed. Tuesday Chipotle Mexican Grill is set to report earnings after the bell, followed by a conference call at 4:30 p.m. What history shows: Data from Bespoke Investment Group shows Chipotle beats earnings expectations 76% of the time and averages a 1.7% gain on earnings day. What history shows: Bespoke data shows Disney beats earnings per share estimates nearly 80% of the time. What history shows: PayPal earnings have beaten analyst earnings expectations nine of the last 10 quarter, according to FactSet.

☆ Top Wall Street analysts pick these stocks to climb 2023’s wall of worry
▼ + stars: | 2023-01-22 | by ( Tipranks.Com Staff | ) www.cnbc.com time to read: +7 min

To help with the process, here are five stocks chosen by Wall Street's top analysts, according to TipRanks, a platform that ranks analysts based on their past performances. Nonetheless, Monness Crespi Hardt analyst Brian White expects the results to be in line with, or marginally above, Street expectations. Looking ahead, White sees pent-up demand for iPhones come into play in the forthcoming quarters, once Apple overcomes the production snags. (See Spotify Stock Chart on TipRanks) White is particularly upbeat about the waning mobile app store monopolies, after the European Union passed the Digital Markets Act last year. The analyst is also placed 431st among more than 8,000 analysts on TipRanks.

☆ A buzzy healthcare startup breaks down how it 'overextended' and is ditching its plans to build hundreds of clinics despite a $100 million investment from CVS
▼ + stars: | 2023-01-13 | by ( Rebecca Torrence | Blake Dodge | ) www.businessinsider.com time to read: +4 min

Carbon Health on Monday landed $100 million from CVS Health as digital-health funding slows. Its CEO, Eren Bali, said it took a valuation hit to get clean terms for its long-term success. In digital health's dismal funding market, Carbon Health just notched a big win. The startup, which operates clinics offering urgent and primary care, announced on Monday that it snagged $100 million in Series D funding from CVS Health Ventures. The pharmacy giant also said it would open Carbon Health clinics at some CVS Health locations.

☆ CVS's acquisition of Aetna will be a tailwind for earnings, says DCLA's Sarat Sethi
▼ + stars: | 2023-01-10 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCVS's acquisition of Aetna will be a tailwind for earnings, says DCLA's Sarat SethiSarat Sethi, Douglas C. Lane Associates managing partner, joins 'Power Lunch' to discuss finding opportunities in today's market.

Search resuls for: "CVS's"

25 mentions found